Jw Life Science Corp (KO:234080) — Market Cap & Net Worth
Market Cap & Net Worth: Jw Life Science Corp (234080)
Jw Life Science Corp (KO:234080) has a market capitalization of $114.80 Million (₩169.40 Billion) as of September 17, 2026. Listed on the KO stock exchange, this Korea-based company holds position #18745 globally and #869 in its home market, demonstrating a -1.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jw Life Science Corp's stock price ₩10940.00 by its total outstanding shares 15484554 (15.48 Million). Also see Jw Life Science Corp balance sheet assets for a full breakdown of the balance sheet.
Jw Life Science Corp Market Cap History: 2016 to 2026
Jw Life Science Corp's market capitalization history from 2016 to 2026. Data shows change from $120.56 Million to $114.80 Million (-4.71% CAGR). Also see Jw Life Science Corp cash conversion from operations for how efficiently the company converts equity into cash flow.
Jw Life Science Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jw Life Science Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 234080 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Jw Life Science Corp's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Jw Life Science Corp's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $120.56 Million | $132.29 Billion | $15.16 Billion | 0.00x | 0.01x |
| 2017 | $190.17 Million | $143.60 Billion | $16.78 Billion | 0.00x | 0.01x |
| 2018 | $203.13 Million | $155.23 Billion | $15.82 Billion | 0.00x | 0.01x |
| 2019 | $187.94 Million | $170.22 Billion | $21.94 Billion | 0.00x | 0.01x |
| 2020 | $201.89 Million | $183.52 Billion | $16.87 Billion | 0.00x | 0.01x |
| 2021 | $139.64 Million | $169.82 Billion | $12.91 Billion | 0.00x | 0.01x |
| 2022 | $127.50 Million | $188.93 Billion | $14.96 Billion | 0.00x | 0.01x |
| 2023 | $135.05 Million | $206.86 Billion | $28.14 Billion | 0.00x | 0.00x |
| 2024 | $114.17 Million | $222.48 Billion | $43.99 Billion | 0.00x | 0.00x |
| 2025 | $134.84 Million | $257.83 Billion | $28.61 Billion | 0.00x | 0.00x |
Competitor Companies of 234080 by Market Capitalization
Companies near Jw Life Science Corp in the global market cap rankings as of September 17, 2026. Review Jw Life Science Corp tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Jw Life Science Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Jw Life Science Corp Historical Marketcap From 2016 to 2026
Between 2016 and today, Jw Life Science Corp's market cap moved from $120.56 Million to $ 114.80 Million, with a yearly change of -4.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩114.80 Million | -14.86% |
| 2025 | ₩134.84 Million | +18.11% |
| 2024 | ₩114.17 Million | -15.46% |
| 2023 | ₩135.05 Million | +5.93% |
| 2022 | ₩127.50 Million | -8.69% |
| 2021 | ₩139.64 Million | -30.83% |
| 2020 | ₩201.89 Million | +7.42% |
| 2019 | ₩187.94 Million | -7.48% |
| 2018 | ₩203.13 Million | +6.82% |
| 2017 | ₩190.17 Million | +57.73% |
| 2016 | ₩120.56 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Jw Life Science Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $114.80 Million USD |
| MoneyControl | $114.80 Million USD |
| MarketWatch | $114.80 Million USD |
| marketcap.company | $114.80 Million USD |
| Reuters | $114.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jw Life Science Corp
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed … Read more